Table 1.
Demographic, diagnostic, and procedural characteristics of the study patients.
| Total population (95% CI for mean) | Non‐MACE group (n = 3904) | MACE group (n = 610) | p Value | |
|---|---|---|---|---|
| Age (year) | 62.1 (61.8–62.5) | 61.5 | 66.2 | <.001 |
| Sex (male, %) | 77.5 | 78.0 | 74.3 | .042 |
| BMI (kg/m2) | 27.2 (27.8–28.5) | 27.9 | 26.6 | .032 |
| Risk factors | ||||
| FH (%) | 17.5 | 18.2 | 13.4 | .004 |
| DM (%) | 41.8 | 40.2 | 51.8 | <.001 |
| HTN (%) | 46.3 | 45.7 | 50.5 | .029 |
| DLP (%) | 53.7 | 49.7 | 52.2 | .032 |
| C/S (%) | 46.0 | 45.2 | 46.1 | .727 |
| O/A (%) | 16.2 | 16.1 | 16.6 | .813 |
| Past medical history | ||||
| Previous STEMI (%) | 4.1 | 3.7 | 7.0 | <.001 |
| Previous non‐STEMI (%) | 2.0 | 1.8 | 3.6 | .005 |
| CHF (%) | 2.9 | 2.1 | 8.2 | <.001 |
| DHF hospitalization (%) | 1.5 | 5.2 | 0.9 | <.001 |
| CVA (%) | 3.5 | 2.8 | 7.4 | .001 |
| COPD (%) | 1.9 | 1.8 | 2.6 | .150 |
| CKD (%) | 1.8 | 1.2 | 6.1 | <.001 |
| ESRD (on dialysis) (%) | 0.2 | 0.1 | 1.0 | .001 |
| Prior CPR (%) | 2.0 | 1.7 | 3.9 | .001 |
| Previous PCI (%) | 10.7 | 10.2 | 14.1 | .006 |
| Previous CABG (%) | 5.6 | 5.3 | 7.5 | .029 |
| Echocardiography | ||||
| LVEF (%) | 41.2 (40.9–41.4) | 41.7 | 38.0 | <.001 |
| Significant VHD (%) | 1.3 | 0.9 | 4.1 | <.001 |
| RV function (%) | ||||
| Normal | 66.8 | 68.2 | 57.5 | <.001 |
| Mildly impaired | 27.0 | 26.6 | 29.8 | |
| Moderately impaired | 5.7 | 4.9 | 11.1 | |
| Severely impaired | 0.5 | 0.3 | 1.5 | |
| Electrocardiogram | ||||
| AF rhythm (%) | 1.0 | 0.7 | 2.6 | <.001 |
| High degree AVB (%) | 0.9 | 0.7 | 1.8 | .017 |
| LBBB (%) | 1.2 | 1.1 | 2.1 | .046 |
| RBBB (%) | 3 | 2.9 | 3.9 | .163 |
| LVH criteria (%) | 0.1 | 0.1 | 0.2 | .582 |
| Q wave (%) | 29.4 | 28.9 | 32.3 | .094 |
| Frequent PVC (%) | 1.0 | 0.9 | 1.3 | .373 |
| Laboratory tests | ||||
| WBC (×103/dL) | 11.34 (11.2–11.4) | 11.1 | 12.3 | <.001 |
| Hb (g/dL) | 14.9 (14.8–15.0) | 15.0 | 14.4 | <.001 |
| PLT (×106/dL) | 243.3 (241.1–245.5) | 242.9 | 246.2 | .372 |
| Cr (mg/dL) | 1.01 (1.00–1.03) | 0.9 | 1.1 | <.001 |
| Procedural parameters | ||||
| P‐D time (min) | 530.2 (507.7–552.7) | 534.4 | 503.3 | .355 |
| D‐D time (min) | 77.8 (75.8–79.8) | 78.3 | 74.7 | .229 |
| P‐D time (min) | 608.0 (585.3–630.8) | 612.7 | 578.0 | .307 |
| Lesion length (mm) | 28.0 (27.7–28.9) | 27.6 | 30.8 | .003 |
| IIb/IIIa in administration (%) | 50.8 | 51.4 | 47.0 | .045 |
| In‐stent thrombosis (%) | 1.0 | 1.0 | 1.1 | 1.000 |
Abbreviations: AF, atrial fibrillation; AVB, atrioventricular block; BMI, body mass index; C/S, cigarette smoker; CABG, coronary artery bypass grafting; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; Cr, creatinine; CVA, cerebrovascular events; D‐D time, door‐to‐device time; DHF, decompensated heart failure; DLP, dyslipidemia; DM, diabetes mellitus; ESRD, end‐stage renal disease; FH, family history; Hb, hemoglobin; HTN, hypertension; LBBB, left bundle branch block; LVEF, left ventricular ejection fraction; LVH, left ventricular hypertrophy; O/A, opium addiction; P‐D time, pain‐to‐device time; P‐D time, pain‐to‐door time; PLT, platelets; PVC, premature ventricular contraction; RBBB, right bundle branch block; RV, right ventricle; VHD, valvular heart disease; WBC, white blood cells.